This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
There are thirty or more different brands of the blood-pressure-raising principle of the suprarenal gland on the market, five being in this country alone. These products are identical so far as their chief constituent is concerned; they differ, however as to the solvent and the preservative used. The processes of manufacture of some of them are patented; all of them are sold under trade names.
Until two years ago there was no common name applicable to this active principle; whenever reference was made to it a trade name had to be used. At that time the Council on Pharmacy and Chemistry, realizing the need of a generic term, adopted "epinephrin" as such a term. This name was selected in part because Abel had adopted it in 1899; in part because, so far as could be discovered, it was the name under which, through Abel's publications, the substance first appeared in
THE NAME "EPINEPHRIN" VERSUS THE NAME "ADRENALIN". JAMA. 1911;LVI(12):901. doi:10.1001/jama.1911.02560120041021
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: